Robert Mannel to Adjuvants, Immunologic
This is a "connection" page, showing publications Robert Mannel has written about Adjuvants, Immunologic.
Connection Strength
0.035
-
A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study. Ann Oncol. 2017 May 01; 28(5):996-1004.
Score: 0.035